Silexion Therapeutics Corp - 8-K Filing
Silexion Therapeutics Corp entered into an inducement agreement on May 15, 2026, with holders of 1,995,092 warrants to exercise them at $0.50 per share in exchange for new warrants (New Warrants) covering up to 3,990,184 shares also exercisable at $0.50 per share. The company expects gross proceeds of approximately $1 million from the transaction and has engaged H.C. Wainwright & Co., LLC as placement agent, agreeing to pay a 7% cash fee plus additional expenses. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 9.01 Financial Statements and Exhibits (d) Exhibits 10)
Tickers: $SLXN